The role of glucocorticoid in SIRP alpha and SHP-1 gene expression in AIHA patients


Autoria(s): ALMEIDA, Ana Carolina de; BARBOSA, Soraya Massaro; BARJAS-CASTRO, Maria de Lourdes; OLALLA-SAAD, Sara Teresinha; CONDINO-NETO, Antonio
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2009

Resumo

The aim of this work was to evaluate the regulation of SIRP alpha, an inhibitory phagocyte receptor, and the phosphatase SHP-1 in monocytes of patients with autoimmune hemolytic anemia, and the role of dexamethasone on SIRP alpha and SHP-1 gene expression and erythrophagocytosis in vitro. SIRP alpha and SHP-1 expression was higher in monocytes from AIHA patients compared with normal, returning to normal after glucocorticoid therapy. SIRP alpha and SHP-1 mRNA expression was upregulated in healthy monocytes treated with dexamethasone compared with basal; however, the erythrophagocytic ability was not altered. Our results point to a minor role of SIRP alpha and SHP-1 in determining AIHA.</.

National Council for Technological and Scientific Development (CNPq)[141602/2005-8]

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Identificador

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, v.31, n.4, p.636-640, 2009

0892-3973

http://producao.usp.br/handle/BDPI/28288

10.3109/08923970902939256

http://dx.doi.org/10.3109/08923970902939256

Idioma(s)

eng

Publicador

TAYLOR & FRANCIS INC

Relação

Immunopharmacology and Immunotoxicology

Direitos

restrictedAccess

Copyright TAYLOR & FRANCIS INC

Palavras-Chave #AUTOIMMUNE HEMOLYTIC-ANEMIA #IN-VITRO #PHAGOCYTOSIS #MONOCYTES #ERYTHROPHAGOCYTOSIS #CORTICOSTEROIDS #HYDROCORTISONE #MACROPHAGES #THERAPY #SHPS-1 #Immunology #Pharmacology & Pharmacy #Toxicology
Tipo

article

original article

publishedVersion